ArticleScientific reports2026
Systemic sclerosis in children and older juvenile-onset patients: real-life map by the Egyptian college of Rheumatology.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this work was to present the demographic and clinical features of children with juvenile systemic sclerosis (JSSc) compared to their older juvenile-onset (Jo-SSc) counterparts. The study included 12 JSSc children (< 16 years) and 54 Jo-SSc patients > 16 years (including adolescents and adults) recruited from 15 tertiary care centers across Egypt. Patients were classified as diffuse (dcSSc), limited cutaneous SSc (lcSSc) and overlap. The mean age at disease onset was 14 ± 2.5 years. Patients were 62 females and 4 males (F: M 15.5:1); 37 lcSSc, 26 dcSSc and 3 overlap. Disease features were generally comparable across five regions of Egypt. Pitting scars and hand puffiness were significantly more frequent in JSSc (58.3% and 41.7%) compared to Jo-SSc (16.7% and 14.8%) (p = 0.006 and p = 0.049, respectively) while pulmonary hypertension was more common in Jo-SSc (40.7% vs. 8.3%, p = 0.045). All males, currently with Jo-SSc, had gastrointestinal involvement versus n = 24 (38.7%) in females, p < 0.0001. To conclude, SSc in children and in those who grow into adulthood remains a rare disease. Pitting scars and hand puffiness were more frequent in children with JSSc while pulmonary hypertension became prominent as they grew. Children characteristics are special for each nation yet with similarities in some features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.